The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Aduro Biotech
Patents, Royalties, Other Intellectual Property - UCLA
 
Honoraria - Merck; Roche
Research Funding - Polaris
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bayer; Bristol-Myers Squibb; Pierre Fabre
Travel, Accommodations, Expenses - Bristol-Myers Squibb
Phase 2, multicenter study of the EZH2 inhibitor tazemetostat as monotherapy in adults with relapsed or refractory (R/R) malignant mesothelioma (MM) with BAP1 inactivation.
 
Marjorie Glass Zauderer
Consulting or Advisory Role - AstraZeneca/MedImmune; Sellas Life Sciences
Research Funding - Bristol-Myers Squibb (Inst); Epizyme (Inst); MedImmune (Inst); Millennium (Inst); Polaris (Inst); Sellas Life Sciences (Inst); Verastem (Inst)
 
Peter Szlosarek
No Relationships to Disclose
 
Sylvestre Le Moulec
No Relationships to Disclose
 
Sanjay Popat
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Guardant Health; Lilly; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; Novartis; Pfizer; Roche
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Epizyme (Inst); Lilly (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme
 
Paul Taylor
No Relationships to Disclose
 
David Planchard
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; MSD; Novartis; Pfizer; Roche; Sanofi/Aventis
 
Arnaud Scherpereel
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Roche
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Roche
 
Thierry Jahan
Research Funding - Acerta Pharma (Inst); Aduro Biotech (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Epizyme (Inst); Kadmon (Inst); Lilly (Inst); Polaris (Inst)
 
Marianna Koczywas
Speakers' Bureau - AstraZeneca
 
Martin Forster
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Lilly; Merck; Novartis; Pfizer
Travel, Accommodations, Expenses - Boehringer Ingelheim; Lilly; Merck; MSD; Pfizer; Roche
 
Robert B. Cameron
No Relationships to Disclose
 
Tobias Peikert
Consulting or Advisory Role - Epizyme
 
Carly Campbell
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
 
Inbal Sapir
Employment - Epizyme
Stock and Other Ownership Interests - Baxalta
Travel, Accommodations, Expenses - Baxalta; Shire
 
Alice McDonald
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
Research Funding - Bristol-Myers Squibb; Epizyme; MedImmune; Sellas Life Sciences; Verastem
 
Coreen Oei
Stock and Other Ownership Interests - GlaxoSmithKline; Johnson & Johnson
Consulting or Advisory Role - Epizyme
 
Alicia Clawson
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
 
Maria Roche
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
 
Dean A. Fennell
No Relationships to Disclose